| CASE REPORT |
|
| Year : 2022 | Volume
: 19
| Issue : 1 | Page : 60 |
|
|
An atypical case report of extensive mucormycotic osteomyelitis of maxilla as a consequence of post-COVID complication
Ayyaswamy Indira Aswin1, Samraj Gunasekaran2, Prasanth Thankappan1, T Isaac Joseph1
1 Department of Oral Pathology, Sree Mookambika Institute of Dental Sciences, Kulasekharam, Tamil Nadu, India
2 Department of Oral & Maxillofacial Surgery, Scudder Memorial Hospital, Ranipet, Tamil Nadu, India
Correspondence Address:
Dr. Prasanth Thankappan
Department of Oral Pathology, Sree Mookambika Institute of Dental Sciences, Kulasekharam, Kanyakumari, Tamil Nadu
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/1735-3327.351348
|
|
|
Saprophytic molds such as Mucor, Rhizopus, and Absidia cause mucormycosis, a fungal infection. These saprophytic fungi are common in the environment and have a strong proclivity for invading major blood arteries, causing tissue ischemia, necrosis, and infarction. They have been linked to immunocompromised individuals with a history of diabetic ketoacidosis, corticosteroid medication, HIV infection, malignant lymphomas, and patients currently receiving and recovering from COVID-19 treatment. The foregoing is the case of a 78-year-old COVID-19 recovered male who presented with a primary complaint of upper tooth movement for 1 month and maxillary segmental mobility. The maxillary alveolar process was resected, and histopathological reports revealed mucormycosis, which was treated with antifungal medication and nasolabial flap surgery. For the past 6 months, he has been disease-free. Early detection and treatment may offer a higher chance of successfully minimizing this debilitating condition.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
